INAB In8Bio Inc
Price (delayed)
$0.1825
Market cap
$14.83M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.57
Enterprise value
$8.74M
Highlights
The EPS has increased by 43% YoY and by 24% QoQ
INAB's net income is up by 4.5% from the previous quarter
In8Bio's equity has soared by 69% from the previous quarter but it has decreased by 42% YoY
In8Bio's debt has decreased by 8% from the previous quarter but it has increased by 2.8% YoY
In8Bio's quick ratio has decreased by 9% YoY
Key stats
What are the main financial stats of INAB
Market
Valuations
Earnings
Shares outstanding
81.26M
Market cap
$14.83M
Enterprise value
$8.74M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.91
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$30.67M
Net income
-$30.44M
EBIT
-$30.44M
EBITDA
-$27.78M
Free cash flow
-$24.34M
Per share
Balance sheet
Liquidity
EPS
-$0.57
EPS diluted
-$0.57
Free cash flow per share
-$0.45
Book value per share
$0.2
Revenue per share
$0
TBVPS
$0.39
Total assets
$20.94M
Total liabilities
$6.47M
Debt
$5.03M
Equity
$14.48M
Working capital
$9.5M
Debt to equity
0.35
Current ratio
4.08
Quick ratio
3.61
Net debt/EBITDA
0.22
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-143.3%
Return on equity
-224.6%
Return on invested capital
-228%
Return on capital employed
-170.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INAB stock price
How has the In8Bio stock price performed over time
Intraday
4.58%
1 week
15.8%
1 month
-21.57%
1 year
-82.45%
YTD
-29.04%
QTD
9.94%
Financial performance
How have In8Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$30.67M
Net income
-$30.44M
Gross margin
N/A
Net margin
N/A
INAB's net income is up by 4.5% from the previous quarter
INAB's operating income is up by 4.3% since the previous quarter but it is down by 2.2% year-on-year
Growth
What is In8Bio's growth rate over time
Valuation
What is In8Bio stock price valuation
P/E
N/A
P/B
0.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 43% YoY and by 24% QoQ
In8Bio's equity has soared by 69% from the previous quarter but it has decreased by 42% YoY
INAB's P/B is 57% below its last 4 quarters average of 2.1
Efficiency
How efficient is In8Bio business performance
The return on equity has dropped by 52% year-on-year and by 14% since the previous quarter
The ROA has decreased by 36% YoY and by 10% from the previous quarter
In8Bio's ROIC has decreased by 6% YoY but it has increased by 4.2% from the previous quarter
Dividends
What is INAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INAB.
Financial health
How did In8Bio financials performed over time
The company's current ratio has surged by 122% QoQ but it fell by 11% YoY
The total assets has declined by 38% year-on-year but it is up by 31% since the previous quarter
In8Bio's debt is 65% less than its equity
In8Bio's debt to equity has surged by 75% YoY but it has decreased by 45% QoQ
In8Bio's equity has soared by 69% from the previous quarter but it has decreased by 42% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.